EMA Authorised: Temozolomide Sun (temozolomide) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

The European Medicines Agency has authorised Sun Pharmaceutical's temozolomide product for the treatment of glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temozolomide Sun (temozolomide)

Snippet

Status: Authorised. Therapeutic area: Glioma. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 10/07/2025